PHASE 1/2 STUDY OF BLU-451 IN ADVANCED CANCERS WITH EGFR EXON20 INSERTION MUTATIONS

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

CTRC Inpatient
University of Colorado Hospital

Principal Investigator
Photograph of Erin Schenk,  MD, PhD

Erin Schenk, MD, PhD

Study ID

Protocol Number: 22-0293

More information available at ClinicalTrials.gov: NCT05241873

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers